Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2006 1
2007 2
2008 2
2009 3
2010 3
2011 2
2012 4
2014 3
2015 4
2018 2
2020 3
2021 2
2022 3
2023 3
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.
Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, Groen HJ, McRae SE, Widder J, Feng L, van den Borne BE, Munsell MF, Hurkmans C, Berry DA, van Werkhoven E, Kresl JJ, Dingemans AM, Dawood O, Haasbeek CJ, Carpenter LS, De Jaeger K, Komaki R, Slotman BJ, Smit EF, Roth JA. Chang JY, et al. Lancet Oncol. 2015 Jun;16(6):630-7. doi: 10.1016/S1470-2045(15)70168-3. Epub 2015 May 13. Lancet Oncol. 2015. PMID: 25981812 Free PMC article. Clinical Trial.
An Evidence-Based Rationale for Dose De-escalation of Subcutaneous Atezolizumab.
Kicken MP, Deenen MJ, Moes DJAR, Hendrikx JJMA, van den Borne BEEM, Dumoulin DW, van der Wekken AJ, van den Heuvel MM, Ter Heine R. Kicken MP, et al. Among authors: van den borne beem. Target Oncol. 2024 Sep;19(5):779-787. doi: 10.1007/s11523-024-01087-4. Epub 2024 Jul 31. Target Oncol. 2024. PMID: 39085452 Free PMC article.
Strengths and challenges in current lung cancer care: Timeliness and diagnostic procedures in six Dutch hospitals.
Genet SAAM, Visser E, Youssef-El Soud M, Belderbos HNA, Stege G, de Saegher MEA, Westeinde SCV', Brunsveld L, Broeren MAC, van de Kerkhof D, Eduati F, van den Borne BEEM, Scharnhorst V. Genet SAAM, et al. Among authors: van den borne beem. Lung Cancer. 2024 Mar;189:107477. doi: 10.1016/j.lungcan.2024.107477. Epub 2024 Jan 22. Lung Cancer. 2024. PMID: 38271919 Free article.
Open communication between patients and relatives about illness & death in advanced cancer-results of the eQuiPe Study.
Haaksman M, Ham L, Brom L, Baars A, van Basten JP, van den Borne BEEM, Hendriks MP, de Jong WK, van Laarhoven HWM, van Lindert ASR, Mandigers CMPW, van der Padt-Pruijsten A, Smilde TJ, van Zuylen LC, van Vliet LM, Raijmakers NJH. Haaksman M, et al. Among authors: van den borne beem. Support Care Cancer. 2024 Mar 6;32(4):214. doi: 10.1007/s00520-024-08379-5. Support Care Cancer. 2024. PMID: 38446248 Free PMC article.
The association of body mass index with safety and effectiveness of first-line carboplatin-based chemotherapy in patients with metastatic non-small cell lung cancer.
Kicken MP, Kilinc HD, Cramer-van der Welle CM, Houterman S, van den Borne BEEM, Smit AAJ, van de Garde EMW, Deenen MJ; Santeon NSCLC study group. Kicken MP, et al. Among authors: van den borne beem. Cancer Treat Res Commun. 2023;34:100676. doi: 10.1016/j.ctarc.2022.100676. Epub 2022 Dec 23. Cancer Treat Res Commun. 2023. PMID: 36592497 Free article.
Liquid biopsy-based decision support algorithms for diagnosis and subtyping of lung cancer.
Visser E, Genet SAAM, de Kock RPPA, van den Borne BEEM, Youssef-El Soud M, Belderbos HNA, Stege G, de Saegher MEA, van 't Westeinde SC, Brunsveld L, Broeren MAC, van de Kerkhof D, Deiman BALM, Eduati F, Scharnhorst V. Visser E, et al. Among authors: van den borne beem. Lung Cancer. 2023 Apr;178:28-36. doi: 10.1016/j.lungcan.2023.01.014. Epub 2023 Feb 1. Lung Cancer. 2023. PMID: 36773458 Free article.
Development and Portability of a Text Mining Algorithm for Capturing Disease Progression in Electronic Health Records of Patients With Stage IV Non-Small Cell Lung Cancer.
Verschueren MV, Abedian Kalkhoran H, Deenen M, van den Borne BEEM, Zwaveling J, Visser LE, Bloem LT, Peters BJM, van de Garde EMW. Verschueren MV, et al. Among authors: van den borne beem. JCO Clin Cancer Inform. 2024 Oct;8:e2400053. doi: 10.1200/CCI.24.00053. Epub 2024 Oct 4. JCO Clin Cancer Inform. 2024. PMID: 39365963 Free PMC article.
Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer.
Gijtenbeek RGP, van der Noort V, Aerts JGJV, Staal-van den Brekel JA, Smit EF, Krouwels FH, Wilschut FA, Hiltermann TJN, Timens W, Schuuring E, Janssen JDJ, Goosens M, van den Berg PM, de Langen AJ, Stigt JA, van den Borne BEEM, Groen HJM, van Geffen WH, van der Wekken AJ. Gijtenbeek RGP, et al. Among authors: van den borne beem. ERJ Open Res. 2022 Oct 17;8(4):00239-2022. doi: 10.1183/23120541.00239-2022. eCollection 2022 Oct. ERJ Open Res. 2022. PMID: 36267895 Free PMC article.
41 results